ATC Group: M01C Specific antirheumatic agents

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01C in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01C Specific antirheumatic agents

Group M01C contents

Code Title
M01CA Quinolines
M01CB Gold preparations
M01CC Penicillamine and similar agents
M01CX Other specific antirheumatic agents

Active ingredients in M01C

Active Ingredient Description
Auranofin

Auranofin is an orally available compound, used to treat rheumatoid arthritis, with anti-inflammatory activities. The main mechanism of action of auranofin is through the inhibition of reduction/oxidation (redox) enzymes such as thioredoxin reductase (TrxR). The thiol ligand contained in auranofin has a high affinity for thiol and selenol groups, to which it forms stable, and irreversible, adducts. Redox enzymes such as TrxR are essential to many cellular processes, particularly in maintaining the intracellular levels of reactive oxygen species (ROS).

Bucillamine
Iguratimod
Penicillamine

Penicillamine is a chelating agent which aids the elimination from the body of certain heavy metal ions, including copper, lead and mercury, by forming stable soluble complexes with them that are readily excreted by the kidney.

Sodium aurothiomalate

Related product monographs

Title Information Source Document Type  
CUPRIMINE Capsule FDA, National Drug Code (US) MPI, US: SPL/Old
PENICILLAMINE Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC